RECIST 1.1-Update and clarification: From the RECIST committee

Lawrence H Schwartz; Saskia Litière; Elisabeth de Vries; Robert Ford; Stephen Gwyther; Sumithra Mandrekar; Lalitha Shankar; Jan Bogaerts; Alice Chen; Janet Dancey; Wendy Hayes; F Stephen Hodi; Otto S Hoekstra; Erich P Huang; Nancy Lin; Yan Liu; Patrick Therasse; Jedd D Wolchok; Lesley Seymour

doi:https://doi.org/10.1016/j.ejca.2016.03.081

RECIST 1.1-Update and clarification: From the RECIST committee

Lawrence H Schwartz, Saskia Litière, Elisabeth de Vries, Robert Ford, Stephen Gwyther, Sumithra Mandrekar, Lalitha Shankar, Jan Bogaerts, Alice Chen, Janet Dancey, Wendy Hayes, F Stephen Hodi, Otto S Hoekstra, Erich P Huang, Nancy Lin, Yan Liu, Patrick Therasse, Jedd D Wolchok, Lesley Seymour

Radiology and Nuclear Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

978 Citations (Scopus)

Abstract

The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published in 2000, based on the original World Health Organisation guidelines first published in 1981. In 2009, revisions were made (RECIST 1.1) incorporating major changes, including a reduction in the number of lesions to be assessed, a new measurement method to classify lymph nodes as pathologic or normal, the clarification of the requirement to confirm a complete response or partial response and new methodologies for more appropriate measurement of disease progression. The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication.

Original language	English
Pages (from-to)	132-7
Number of pages	6
Journal	European Journal of Cancer
Volume	62
DOIs	https://doi.org/10.1016/j.ejca.2016.03.081
Publication status	Published - Jul 2016

Keywords

Journal Article

Access to Document

https://doi.org/10.1016/j.ejca.2016.03.081

Cite this

Schwartz, L. H., Litière, S., de Vries, E., Ford, R., Gwyther, S., Mandrekar, S., Shankar, L., Bogaerts, J., Chen, A., Dancey, J., Hayes, W., Hodi, F. S., Hoekstra, O. S., Huang, E. P., Lin, N., Liu, Y., Therasse, P., Wolchok, J. D., & Seymour, L. (2016). RECIST 1.1-Update and clarification: From the RECIST committee. European Journal of Cancer, 62, 132-7. https://doi.org/10.1016/j.ejca.2016.03.081

@article{0f9e59bb6f7f46229842d997e97d2b44,

title = "RECIST 1.1-Update and clarification: From the RECIST committee",

abstract = "The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published in 2000, based on the original World Health Organisation guidelines first published in 1981. In 2009, revisions were made (RECIST 1.1) incorporating major changes, including a reduction in the number of lesions to be assessed, a new measurement method to classify lymph nodes as pathologic or normal, the clarification of the requirement to confirm a complete response or partial response and new methodologies for more appropriate measurement of disease progression. The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication.",

keywords = "Journal Article",

author = "Schwartz, {Lawrence H} and Saskia Liti{\`e}re and {de Vries}, Elisabeth and Robert Ford and Stephen Gwyther and Sumithra Mandrekar and Lalitha Shankar and Jan Bogaerts and Alice Chen and Janet Dancey and Wendy Hayes and Hodi, {F Stephen} and Hoekstra, {Otto S} and Huang, {Erich P} and Nancy Lin and Yan Liu and Patrick Therasse and Wolchok, {Jedd D} and Lesley Seymour",

year = "2016",

month = jul,

doi = "https://doi.org/10.1016/j.ejca.2016.03.081",

language = "English",

volume = "62",

pages = "132--7",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

Schwartz, LH, Litière, S, de Vries, E, Ford, R, Gwyther, S, Mandrekar, S, Shankar, L, Bogaerts, J, Chen, A, Dancey, J, Hayes, W, Hodi, FS, Hoekstra, OS, Huang, EP, Lin, N, Liu, Y, Therasse, P, Wolchok, JD & Seymour, L 2016, 'RECIST 1.1-Update and clarification: From the RECIST committee', European Journal of Cancer, vol. 62, pp. 132-7. https://doi.org/10.1016/j.ejca.2016.03.081

TY - JOUR

T1 - RECIST 1.1-Update and clarification

T2 - From the RECIST committee

AU - Schwartz, Lawrence H

AU - Litière, Saskia

AU - de Vries, Elisabeth

AU - Ford, Robert

AU - Gwyther, Stephen

AU - Mandrekar, Sumithra

AU - Shankar, Lalitha

AU - Bogaerts, Jan

AU - Chen, Alice

AU - Dancey, Janet

AU - Hayes, Wendy

AU - Hodi, F Stephen

AU - Hoekstra, Otto S

AU - Huang, Erich P

AU - Lin, Nancy

AU - Liu, Yan

AU - Therasse, Patrick

AU - Wolchok, Jedd D

AU - Seymour, Lesley

PY - 2016/7

Y1 - 2016/7

N2 - The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published in 2000, based on the original World Health Organisation guidelines first published in 1981. In 2009, revisions were made (RECIST 1.1) incorporating major changes, including a reduction in the number of lesions to be assessed, a new measurement method to classify lymph nodes as pathologic or normal, the clarification of the requirement to confirm a complete response or partial response and new methodologies for more appropriate measurement of disease progression. The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication.

AB - The Response Evaluation Criteria in Solid Tumours (RECIST) were developed and published in 2000, based on the original World Health Organisation guidelines first published in 1981. In 2009, revisions were made (RECIST 1.1) incorporating major changes, including a reduction in the number of lesions to be assessed, a new measurement method to classify lymph nodes as pathologic or normal, the clarification of the requirement to confirm a complete response or partial response and new methodologies for more appropriate measurement of disease progression. The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication.

KW - Journal Article

U2 - https://doi.org/10.1016/j.ejca.2016.03.081

DO - https://doi.org/10.1016/j.ejca.2016.03.081

M3 - Article

C2 - 27189322

SN - 0959-8049

VL - 62

SP - 132

EP - 137

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -